By proceeding, you agree to our Terms of Use and Privacy Policy.
Invicro was founded with a mission of improving the role and function of imaging in translational drug discovery and development.
16-18 March 2022
IO360°convenes stakeholders from the science and business communities to report on the latest data impacting IO to fight a wider range of cancers.
Event Ended
USA
Paid
New York
26-28 July 2022
With two prostate cancer-focused approvals in the last year, RLT is finally getting the attention it deserves from investors, biotech, and the wider oncology field. Though still the 3rd line of exotic therapy, the ever-growing pipeline of therapeutic
Boston
06-09 February 2023
Now more than ever, the important work of this clinical research community requires collaboration and innovation.
Hybrid
Orlando
25-27 July 2023
The 2nd Annual Targeted Radiopharmaceuticals Summit US is set to take place, highlighting the industry's progress and growth as more compounds are moving through clinical trials. This event is the only industry-led meeting dedicated to accelerating T